UNH
UnitedHealth Group Incorporated
Quarterly revenue, EPS, free cash flow, valuation, and Rule of 40 scores for UnitedHealth Group Incorporated.
Coverage
UnitedHealth's First Revenue Decline in Decades. The $439B Guidance Problem.
UnitedHealth guided 2026 revenue to $439B — down from $448B in 2025. It's the company's first annual revenue decline in decades, and the stock is paying for it.
UnitedHealth Strong Buy
Insiders cashing out 22.8M; technical $148.29, consensus $230.63.
UNH Decline Signals Unease
Rising costs or tighter margins in healthcare; drop suggests consumer demand worries.
UnitedHealth Extends Decline
Down -20%, erasing $65B market cap—worst day since April 2025.
UnitedHealth Turnaround Materializing
12% revenue growth; guidance shows improvement vs 2025 margins—floor at 17x forward earnings.
Latest: $112.03B (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | $65.11B |
| 2020Q4 | $65.47B |
| 2021Q1 | $70.20B |
| 2021Q2 | $71.32B |
| 2021Q3 | $72.34B |
| 2021Q4 | $73.74B |
| 2022Q1 | $80.15B |
| 2022Q2 | $80.33B |
| 2022Q3 | $80.89B |
| 2022Q4 | $82.79B |
| 2023Q1 | $91.93B |
| 2023Q2 | $92.90B |
| 2023Q3 | $92.36B |
| 2023Q4 | $94.43B |
| 2024Q1 | $99.80B |
| 2024Q2 | $98.86B |
| 2024Q3 | $100.82B |
| 2024Q4 | $100.81B |
| 2025Q1 | $109.58B |
| 2025Q2 | $111.62B |
| 2025Q3 | $113.16B |
| 2025Q4 | $113.22B |
| 2026Q1 | $111.72B |
| 2026Q2 | $112.03B |
Latest: $6.04 (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | $3.30 |
| 2020Q4 | $2.30 |
| 2021Q1 | $5.08 |
| 2021Q2 | $4.46 |
| 2021Q3 | $4.28 |
| 2021Q4 | $4.26 |
| 2022Q1 | $5.27 |
| 2022Q2 | $5.34 |
| 2022Q3 | $5.55 |
| 2022Q4 | $5.02 |
| 2023Q1 | $5.95 |
| 2023Q2 | $5.82 |
| 2023Q3 | $6.24 |
| 2023Q4 | $5.85 |
| 2024Q1 | -$1.53 |
| 2024Q2 | $4.54 |
| 2024Q3 | $6.51 |
| 2024Q4 | $5.99 |
| 2025Q1 | $6.85 |
| 2025Q2 | $3.74 |
| 2025Q3 | $2.59 |
| 2025Q4 | $0.01 |
| 2026Q1 | $6.90 |
| 2026Q2 | $6.04 |
Latest: 20.4 (2026Q1)
| Period | Value |
|---|---|
| 2020Q2 | 15.2 |
| 2020Q3 | 16.4 |
| 2020Q4 | 20.2 |
| 2021Q1 | 19.6 |
| 2021Q2 | 24.6 |
| 2021Q3 | 22.6 |
| 2021Q4 | 26.0 |
| 2022Q1 | 26.2 |
| 2022Q2 | 25.2 |
| 2022Q3 | 23.3 |
| 2022Q4 | 23.7 |
| 2023Q1 | 20.5 |
| 2023Q2 | 20.5 |
| 2023Q3 | 21.0 |
| 2023Q4 | 21.2 |
| 2024Q1 | 29.2 |
| 2024Q2 | 32.7 |
| 2024Q3 | 37.0 |
| 2024Q4 | 31.9 |
| 2025Q1 | 21.5 |
| 2025Q2 | 13.3 |
| 2025Q3 | 17.9 |
| 2025Q4 | 25.0 |
| 2026Q1 | 20.4 |
Latest: $10.25B (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | $2.57B |
| 2020Q4 | $5.53B |
| 2021Q1 | $5.44B |
| 2021Q2 | $4.98B |
| 2021Q3 | $6.95B |
| 2021Q4 | $2.52B |
| 2022Q1 | $4.76B |
| 2022Q2 | $6.21B |
| 2022Q3 | $17.82B |
| 2022Q4 | -$5.40B |
| 2023Q1 | $15.57B |
| 2023Q2 | $10.20B |
| 2023Q3 | $6.06B |
| 2023Q4 | -$6.15B |
| 2024Q1 | $401M |
| 2024Q2 | $5.89B |
| 2024Q3 | $12.95B |
| 2024Q4 | $1.46B |
| 2025Q1 | $4.56B |
| 2025Q2 | $6.30B |
| 2025Q3 | $5.05B |
| 2025Q4 | $160M |
| 2026Q1 | $8.15B |
| 2026Q2 | $10.25B |
Latest: $905,838,620.00 (2025Q3)
| Period | Value |
|---|---|
| 2018Q1 | $960,981,242.00 |
| 2018Q2 | $962,473,363.00 |
| 2018Q3 | $962,034,200.00 |
| 2019Q1 | $950,343,113.00 |
| 2019Q2 | $947,680,609.00 |
| 2019Q3 | $947,414,929.00 |
| 2020Q1 | $948,379,502.00 |
| 2020Q2 | $950,335,762.00 |
| 2020Q3 | $948,820,710.00 |
| 2021Q1 | $943,702,120.00 |
| 2021Q2 | $942,917,366.00 |
| 2021Q3 | $941,851,250.00 |
| 2022Q1 | $938,171,603.00 |
| 2022Q2 | $935,382,710.00 |
| 2022Q3 | $934,349,073.00 |
| 2023Q1 | $931,032,030.00 |
| 2023Q2 | $926,305,139.00 |
| 2023Q3 | $924,925,293.00 |
| 2024Q1 | $920,385,075.00 |
| 2024Q2 | $923,418,150.00 |
| 2024Q3 | $920,284,334.00 |
| 2025Q1 | $907,140,441.00 |
| 2025Q2 | $905,673,625.00 |
| 2025Q3 | $905,838,620.00 |
Latest: $202.17B (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | $72.48B |
| 2020Q4 | $78.01B |
| 2021Q1 | $83.45B |
| 2021Q2 | $88.43B |
| 2021Q3 | $95.38B |
| 2021Q4 | $97.90B |
| 2022Q1 | $102.67B |
| 2022Q2 | $108.88B |
| 2022Q3 | $126.70B |
| 2022Q4 | $121.31B |
| 2023Q1 | $136.87B |
| 2023Q2 | $147.07B |
| 2023Q3 | $153.14B |
| 2023Q4 | $146.99B |
| 2024Q1 | $147.39B |
| 2024Q2 | $153.28B |
| 2024Q3 | $166.24B |
| 2024Q4 | $167.69B |
| 2025Q1 | $172.25B |
| 2025Q2 | $178.55B |
| 2025Q3 | $183.61B |
| 2025Q4 | $183.77B |
| 2026Q1 | $191.92B |
| 2026Q2 | $202.17B |
Latest results
Company History
Founded by Richard T. Burke as Charter Med Incorporated in Minnesota, initially processing claims for doctors at the Hennepin County Medical Society.
UnitedHealthcare Corporation founded to purchase Charter Med and create a network-based health plan for seniors.
Became a publicly traded company.
Changed name to UnitedHealth Group and reorganized as a holding company for subsidiaries including UnitedHealthcare, Ovations, Uniprise, and Ingenix.
William W. McGuire stepped down as chairman over employee stock options scandal; replaced by Stephen Hemsley as CEO.
Optum formed to provide data and analytics, pharmacy care services, population health, healthcare delivery, and operations.
Optum acquired DaVita Medical Group for $4.3 billion and Equian for $3.2 billion; acquired PatientsLikeMe patient community platform.
Acquired Change Healthcare for $8 billion after antitrust challenges; completed by September.
Subsidiary hit by ransomware, causing disruptions; led to DOJ probes on antitrust and overcharging, with CEO Andrew Witty testifying.
Key Players
showing 6 of 14
The CEO view — 1 appearance →
Similar stocks in Healthcare
Funds we follow holding UNH
By latest reported 13F position value. Market value at quarter-end, not cost basis.
